Article Text

Download PDFPDF
A rare localised nasal CD30+ primary cutaneous T-cell lymphoma following liver transplantation
  1. Quan M Nhu1,2,
  2. Emma Z Du3,
  3. Amirali Kiyani4,
  4. Catherine T Frenette5
  1. 1Department of Internal Medicine, Division of Gastroenterology & Hepatology, Scripps Clinic - Scripps Green Hospital, La Jolla, California, USA
  2. 2Scripps Translational Science Institute, The Scripps Research Institute, La Jolla, California, USA
  3. 3Department of Pathology, Scripps Green Hospital, La Jolla, California, USA
  4. 4Department of Internal Medicine, Maricopa Medical Center, Phoenix, Arizona, USA
  5. 5Scripps Clinic, Scripps Center for Organ Transplantation, La Jolla, California, USA
  1. Correspondence to Dr. Quan M Nhu, Nhu.Quan{at}


Cutaneous T-cell post-transplant lymphoproliferative disorder (PTLD) is a rare clinical presentation that can potentially turn aggressive in solid-organ transplant recipients if not detected and intervened on early. We encountered a rare case of rapidly worsening primary cutaneous CD30-positive, Epstein-Barr virus-negative anaplastic large cell lymphoma (ALCL) of T-cell origin, manifesting as an isolated nasal tip lesion in a 71-year-old man 4 years after orthotopic liver transplantation. Excisional biopsy with partial rhinectomy showed subepithelial diffuse infiltration of medium-to-large lymphoid cells having round-to-irregular nuclei, partially condensed chromatin and prominent nucleoli. Immunophenotypic studies revealed CD30-positive primary cutaneous ALCL. Positron emission tomography/CT imaging revealed a locally active disease, and radiation therapy was initiated with complete response. A high index of suspicion for PTLD when evaluating skin lesions in a post-transplant patient is paramount for its early recognition, prompt diagnosis and timely intervention while the window for curative therapy remains possible.

  • transplantation
  • pathology
  • oncology
  • haematology (incl blood transfusion)
  • liver disease

Statistics from


  • Contributors QMN reviewed the case, performed comprehensive literature review and wrote the manuscript. AK assisted with case review and literature review. EZD assisted with histopathology. QMN and CTF reviewed the manuscript critically. All authors approved the final version.

  • Funding National Center for Advancing Translational Sciences, 10.13039/100006108, NIH/NCATS CTSA 5 UL1 TR001114 and 5KL2 TR001112.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.